Cabozantinib in combination with atezolizumab as first-line therapy for advanced hepatocellular carcinoma: COSMIC-312 phase 3 study design
Year: 2019
Type: article
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3023832674
